Despite posting its highest-ever operating profit, Allianz SE saw a muted reaction from investors. The insurance giant's forecast for 2026,...

The critical challenge for ECHOIQ is no longer technological proof but commercial execution. The company's automated cardiac diagnostics have demonstrated...

The year 2026 is shaping up to be a defining chapter for Siemens Healthineers, marked by a major corporate shift...

February 2026 represented a pivotal moment for global investment flows. Against a backdrop of significant capital rotation, the Vanguard FTSE...

Bayer's latest financial results present a stark dichotomy. While the company's core business operations demonstrate resilience, its bottom line continues...

Greece's premier gambling operator, OPAP, has posted historic revenue figures for its latest fiscal year. However, the celebratory mood among...

For Titomic, the central question is no longer about proving its specialized manufacturing technology works, but about whether it can...

ImmunityBio's impressive full-year 2025 results were met with a severe sell-off, highlighting the persistent volatility that continues to characterize this...

In a strategic move to fortify its executive bench, solid-state battery developer QuantumScape has appointed a new board member with...

Intel's Chief Financial Officer, David Zinsner, signaled a potential strategic advancement for the company's struggling manufacturing division. Speaking at the...